院前、急诊与重症试验中整群随机与个体随机对照的Meta流行病学研究
本研究为Meta流行病学研究,系统检索PubMed和Embase,纳入近十年院前、急诊或重症领域中同时包含至少一项整群随机试验(cRCT)和一项个体随机试验(iRCT)的Meta分析。共识别94项合格Meta分析,其中44.7%报告了随机化类型;65项纳入定量分析,涵盖212项随机对照试验(39项cRCT和173项iRCT)及315,276例患者。主要结局死亡率方面,cRCT与iRCT的绝对ln(OR)均值差为-0.110(95%CI -0.093至0.313),无统计学显著差异;次要结局(住院时间或存活天数类)的绝对Hedges' g均值差为-0.202(95%CI -0.392至-0.012),存在显著差异,cRCT报告的效应量更小。结论提示未来Meta分析需提高随机化类型的报告透明度并在统计上加以考虑。
要点
- 在院前、急诊和重症领域的Meta分析中,整群随机试验与个体随机试验在死亡率效应估计上无显著差异(MD -0.110,95%CI -0.093至0.313)。
- 对于住院时间或存活天数类结局,整群随机试验报告的效应量显著小于个体随机试验(MD -0.202,95%CI -0.392至-0.012)。
- 仅44.7%的合格Meta分析报告了纳入试验的随机化类型(整群或个体),透明度不足。
- 定量分析纳入65项Meta分析、212项RCT(39项cRCT和173项iRCT)、315,276例患者。
- 临床解读Meta分析时需注意随机化类型可能影响非死亡率结局的效应估计,未来Meta分析应考虑随机化类型。
适用人群与场景
- 院前、急诊或重症监护环境中开展的随机对照试验,纳入近十年发表的Meta分析,且该Meta分析同时包含至少一项整群随机试验和一项个体随机试验。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型为Meta流行病学研究,系统检索PubMed和Embase,识别94项合格Meta分析,其中44.7%报告了随机化类型;65项纳入定量分析,涵盖212项RCT(39项cRCT和173项iRCT)及315,276例患者。
- 主要结局死亡率:cRCT与iRCT的绝对ln(OR)均值差为-0.110(95%CI -0.093至0.313),无统计学显著差异。
- 次要结局(住院时间或存活天数类):绝对Hedges' g均值差为-0.202(95%CI -0.392至-0.012),存在显著差异,cRCT报告的效应量更小。
证据类型、等级与局限
- 证据类型为Meta流行病学研究(系统检索并定量合并Meta分析),原文未给出证据等级或推荐强度。
- 局限性:原文指出仅不到一半的Meta分析报告了随机化类型,可能影响结果透明度;未提及其他局限。
对床旁实践的改变
- 在解读院前、急诊和重症领域的Meta分析时,应关注纳入试验的随机化类型;对于住院时间或存活天数类结局,整群随机试验的效应量可能偏小,需谨慎合并。
- 未来开展Meta分析时应报告并考虑随机化类型,以提高透明度并减少潜在偏倚。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Cluster-randomized clinical trials (cRCTs) are pooled with individually randomized clinical trials (iRCTs) in meta-analyses. However, cRCTs are associated with methodological characteristics potentially inducing systematic differences compared with iRCTs. In acute settings, trial inclusion is time-sensitive, exacerbating inclusion-based biases. We conducted a meta-epidemiological study to assess deviations in effect estimates between cRCTs and iRCTs in these settings.
DATA SOURCES: A systematic literature search was conducted in PubMed and Embase.
DATA SELECTION: We screened and identified all meta-analyses in prehospital, emergency, or critical care within the last decade that included at least one cRCT and one iRCT.
DATA EXTRACTION: Data were extracted in duplicate from the meta-analyses. If overlapping trials were identified, results were pooled. The primary outcome was mortality; the secondary outcome comprised length-of-stay- or days-alive-type outcomes.
DATA SYNTHESIS: Using absolute ln(odds ratio [OR]) for mortality and absolute Hedges' g for the secondary outcome, mean differences (MDs) in effect estimates between cRCTs and iRCTs were analyzed using mixed regression models, presented with 95% CIs. We identified 94 eligible meta-analyses; 44.7% reported on randomization type (cRCT or iRCT). We included 65 meta-analyses in quantitative analyses, encompassing 212 randomized clinical trials (39 cRCTs and 173 iRCTs) and 315,276 patients. No statistically significant difference in absolute ln(OR) for mortality between cRCTs and iRCTs was found (MD, -0.110; 95% CI, -0.093 to 0.313). For length-of-stay- or days-alive-type outcomes, a significant difference in absolute Hedges' g was found (MD, -0.202; 95% CI, -0.392 to -0.012).
CONCLUSIONS: A systematic difference between cRCTs and iRCTs in length-of-stay- or days-alive-type outcomes, but not mortality, was identified, with cRCTs reporting smaller effect size magnitudes than iRCTs. With under half of identified meta-analyses reporting on randomization modality, these results highlight the need for improved transparency and statistical consideration of randomization type in future meta-analyses in prehospital, emergency, and critical care.
参考来源
- Lønstrup S, Petersen PL, Bruun NH, et al. Cluster Versus Individual Randomization in Prehospital, Emergency and Critical Care Trials: A Meta-Epidemiological Study. Crit Care Med. 2026. PMID: 42904944. doi:10.1097/CCM.0000000000007386
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。